Artificial Tears Market Outlook to 2024: Global Strategic Business Report 2018 - Preference for Preservative-Free Artificial Tears on Rise - ResearchAndMarkets.com

DUBLIN--()--The "Artificial Tears - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Artificial Tears in US$ Thousand.

The report profiles 49 companies including many key and niche players such as:

  • Akorn, Inc. (USA)
  • Alcon, Inc. (Switzerland)
  • Allergan plc (Ireland)
  • Bausch & Lomb Incorporated (USA)
  • Johnson & Johnson (USA)
  • Novartis International AG (Switzerland)
  • Santen Pharmaceuticals Co, Ltd. (Japan)

Key Topics Covered

1. Introduction, Methodology & Product Definitions

2. Industry Overview

3. Noteworthy Market Trends

  • Companies Focus on New Formulations to Improve Results
  • Preference for Preservative-Free Artificial Tears on Rise
  • Management of Dry Eyes Post Eye Surgery Drives Demand for Artificial Tears
  • Rise in Mobile Workforce and Number of Smartphone Addicts Spurs Growth Prospects
  • An Upswing in Contact Lens Wearers Unfolds New Opportunities
  • Manufacturers Focus Efforts on Formulating the Right Artificial Tears for Contact Lens Wearers
  • Environmental Factors Play an Important Role
  • Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment
  • Direct-to-Customer Promotions: A Primary Marketing Strategy

4. Dry Eye Syndrome - An Overview

5. Product Overview

6. Competitive Landscape

6.1 Focus on Select Global Players

6.2 Product Launches/Approvals/Introductions

6.3 Recent Industry Activity

7. Global Market Perspective

Total Companies Profiled: 49 (including Divisions/Subsidiaries - 54)

  • The United States (19)
  • Canada (3)
  • Japan (3)
  • Europe (14)
    • France (1)
    • Germany (3)
    • The United Kingdom (3)
    • Italy (1)
    • Spain (1)
    • Rest of Europe (9)
  • Asia-Pacific (Excluding Japan) (12)
  • Middle East (1)
  • Africa (2)

For more information about this report visit https://www.researchandmarkets.com/research/9dz3st/artificial_tears?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Optical , Optical Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Optical , Optical Disorders Drugs